SCHEMBL25833792

SCHEMBL25833792

Clc1cc(Cl)c2cc(C3CCCCCCC3)ccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.48
EGLN1 Q9GZT9 9/20 0.40
TRIM58 Q8NG06 1/20 0.40
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
CYP2D6 P10635 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39
ACMSD Q8TDX5 1/20 0.39
DHODH Q02127 2/20 0.39
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38
PRKAB1 Q9Y478 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25833794 0.86 BACE1 (0.47) BACE1EGLN1TRIM58HRH3CYP2D6
SCHEMBL3971869 0.78 BACE1 (0.71) BACE1HRH3CYP2D6SLC6A2SLC6A4
SCHEMBL9248826 0.73 MAPT (0.60) KMT2A
SCHEMBL16573747 0.72 BACE1 (0.41) BACE1GAAKMT2AHRH3CYP2D6
SCHEMBL22777973 0.70 BACE1 (0.49) BACE1HRH3CYP2D6SLC6A2SLC6A4
SCHEMBL29799170 0.70 LMNA (0.46) GAA
SCHEMBL2535170 0.70 LMNA (0.46) GAA
SCHEMBL4331978 0.70 SLC6A2 (0.68) CYP2D6SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL8696003 0.70 GAA (0.52) GAAKMT2ADHODH
SCHEMBL9259735 0.70 ACHE (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023133217-A1 2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES REMIX THERAPEUTICS INC. (US) 2023-07-13 WO disclosed